T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
The Greenbrier Companies
GBX
$1.4B
| $1.15M | ﹤0.01% |
18,844
+2,008
| +12% | +$122K |
|
1902
Avis
CAR
$4.87B
| $1.14M | ﹤0.01% |
14,180
+2,111
| +17% | +$192K |
|
|
ELME
1903
Elme Communities
ELME
$144M
| $1.14M | ﹤0.01% |
74,379
+6,582
| +10% | +$109K |
|
|
CLYM
1904
Climb Bio
CLYM
$955M
| $1.13M | ﹤0.01% |
628,650
-43,916
| -7% | -$159K |
|
1905
Artivion
AORT
$1.42B
| $1.13M | ﹤0.01% |
39,489
+3,950
| +11% | +$110K |
|
1906
Cohu
COHU
$2.77B
| $1.13M | ﹤0.01% |
42,163
+4,422
| +12% | +$116K |
|
1907
MannKind Corp
MNKD
$1.23B
| $1.13M | ﹤0.01% |
175,009
+18,806
| +12% | +$126K |
|
1908
Dime Commercial Bancshares
DCOM
$1.81B
| $1.13M | ﹤0.01% |
36,591
-46,208
| -56% | -$1.49M |
|
1909
Lemonade
LMND
$4.07B
| $1.12M | ﹤0.01% |
30,573
+3,579
| +13% | +$114K |
|
1910
Vicor
VICR
$10.7B
| $1.12M | ﹤0.01% |
23,178
+1,475
| +7% | +$73.7K |
|
1911
Adient
ADNT
$1.58B
| $1.12M | ﹤0.01% |
64,850
+4,999
| +8% | +$99.9K |
|
|
DVAX
1912
DELISTED
Dynavax Technologies
DVAX
| $1.12M | ﹤0.01% |
87,482
+8,699
| +11% | +$105K |
|
|
SCS
1913
DELISTED
Steelcase
SCS
| $1.11M | ﹤0.01% |
94,223
+5,872
| +7% | +$75.5K |
|
1914
Fortrea Holdings
FTRE
$1.69B
| $1.11M | ﹤0.01% |
59,630
+4,260
| +8% | +$83K |
|
1915
Harmonic Inc
HLIT
$1.5B
| $1.11M | ﹤0.01% |
83,905
-53,683
| -39% | -$700K |
|
1916
PureCycle Technologies
PCT
$1.39B
| $1.11M | ﹤0.01% |
108,035
+8,959
| +9% | +$104K |
|
1917
The RealReal
REAL
$1.38B
| $1.1M | ﹤0.01% |
101,035
+7,645
| +8% | +$40.7K |
|
1918
1st Source
SRCE
$2.14B
| $1.1M | ﹤0.01% |
18,917
+1,140
| +6% | +$70.6K |
|
|
CIM
1919
Chimera Investment
CIM
$991M
| $1.1M | ﹤0.01% |
78,703
+7,595
| +11% | +$114K |
|
1920
FB Financial Corp
FBK
$3.09B
| $1.1M | ﹤0.01% |
21,293
+2,341
| +12% | +$122K |
|
1921
Dana Inc
DAN
$3.28B
| $1.09M | ﹤0.01% |
94,640
+8,772
| +10% | +$91.1K |
|
1922
Middlesex Water
MSEX
$1.1B
| $1.09M | ﹤0.01% |
20,713
+1,228
| +6% | +$77.1K |
|
1923
Revolve Group
RVLV
$1.68B
| $1.09M | ﹤0.01% |
32,521
+2,683
| +9% | +$83.1K |
|
1924
Innoviva
INVA
$1.53B
| $1.09M | ﹤0.01% |
62,633
+6,927
| +12% | +$133K |
|
1925
Live Oak Bancshares
LOB
$2.01B
| $1.09M | ﹤0.01% |
27,437
+2,594
| +10% | +$117K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.